Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.
Han X, Zhang WH, Gao HL, Li TJ, Xu HX, Li H, Li PC, Wang X, Yu XJ, Wang WQ, et al. J Clin Lab Anal. 2022 Jul; 36(7):e24517. Epub 2022 May 27.